Concepedia

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial

Unknown author(s)

The Lancet · 2014 · 399 citations · 12 references

Concepts

MedicinePharmacologyPharmacotherapyClinical NeuroscienceClinical PharmacologyNeuropharmacologyDopaminergic PharmacologyNeurodegenerative Disease PharmacotherapyParkinson DiseaseParkinsonian DisordersDopamine Receptor AgonistsDopaminergic Therapy ManagementLong-term EffectivenessMonoamine Oxidase InhibitionMonoamine Oxidase InhibitorsParkinson's Disease PharmacotherapyParkinson’s Disease PharmacotherapyParkinson’s Disease Treatment

References

12

Analysis of Incomplete Multivariate Data

David E. Booth, Joseph L. Schafer · Technometrics · 2000 · 5.7K citations

Public Health, Biostatistics, Categorical Data Analysis +15

Levodopa and the Progression of Parkinson's Disease

New England Journal of Medicine · 2004 · 1.8K citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score

Crispin Jenkinson, Ray Fitzpatrick, Viv Peto et al. · Age and Ageing · 1997 · 1.3K citations

Medicine, Neurology, Differential Item Functioning +14

Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease

New England Journal of Medicine · 1989 · 919 citations

Medicine, Neurology, Pharmacology +14

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease

Andrew J. Lees · BMJ · 1995 · 351 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15